Corvex Q2 revenue $3.8M, net loss $12.8M; contracted ARR ~$22M

Corvex, Inc.

2026-Q2 EPS reported -$8.59 revenue$4,312,000

Q2 revenue $3.8M vs $103K prior year; net loss $12.8M ($5.12/share) vs $3.2M loss.
Adjusted EBITDA -$3.2M; cash $21.7M; deferred revenue $3.7M.
Contracted annualized revenue on live compute ~$22M as of Aug 14, 2026.
Completed transfer of legacy healthcare assets to lender, extinguishing Bridge Loan, $2.5M gain.
Appointed CFO Chance Moreland, VP Michael Craig; added two board members; simplified capital structure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.